Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Dow
McKesson
Colorcon
McKinsey

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Deoxythymidine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Deoxythymidine?

Deoxythymidine is an investigational drug.

There have been 10 clinical trials for Deoxythymidine. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2021.

The most common disease conditions in clinical trials are HIV Infections, Communicable Diseases, and Acquired Immunodeficiency Syndrome. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Zogenix, Inc.

There are two hundred and seventy-seven US patents protecting this investigational drug and thirty international patents.

Recent Clinical Trials for Deoxythymidine
TitleSponsorPhase
Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal CancerFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)Zogenix, Inc.Phase 3
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)Modis Therapeutics, Inc.Phase 3

See all Deoxythymidine clinical trials

Clinical Trial Summary for Deoxythymidine

Top disease conditions for Deoxythymidine
Top clinical trial sponsors for Deoxythymidine

See all Deoxythymidine clinical trials

US Patents for Deoxythymidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Deoxythymidine ⤷  Try it Free Antibody formulations GENENTECH, INC. (South San Francisco, CA) ⤷  Try it Free
Deoxythymidine ⤷  Try it Free Nucleic acid vaccines ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Deoxythymidine ⤷  Try it Free Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease Axovant Sciences GmbH (Basel, CH) ⤷  Try it Free
Deoxythymidine ⤷  Try it Free Multimodal silica-based nanoparticles ⤷  Try it Free
Deoxythymidine ⤷  Try it Free 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof Samumed, LLC (San Diego, CA) ⤷  Try it Free
Deoxythymidine ⤷  Try it Free Nicotinic attenuation of CNS inflammation and autoimmunity Dignity Health (San Francisco, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Deoxythymidine

Drugname Country Document Number Estimated Expiration Related US Patent
Deoxythymidine China CN103533955 2031-04-13 ⤷  Try it Free
Deoxythymidine European Patent Office EP2696894 2031-04-13 ⤷  Try it Free
Deoxythymidine Japan JP2014511704 2031-04-13 ⤷  Try it Free
Deoxythymidine South Korea KR20140043340 2031-04-13 ⤷  Try it Free
Deoxythymidine World Intellectual Property Organization (WIPO) WO2012140127 2031-04-13 ⤷  Try it Free
Deoxythymidine World Intellectual Property Organization (WIPO) WO2005111240 2024-04-30 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Dow
McKesson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.